ChronoSynthNet: a dual-task deep learning model development and validation study for predicting real-time norepinephrine dosage and the early detection of hypotension in patients with septic shock.

IF 2.1 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Cardiovascular diagnosis and therapy Pub Date : 2025-08-30 Epub Date: 2025-08-27 DOI:10.21037/cdt-2025-265
Zeyu Jiang, Shixuan Zhang, Yana Yuan, Jiucun Wang, Zixin Hu
{"title":"ChronoSynthNet: a dual-task deep learning model development and validation study for predicting real-time norepinephrine dosage and the early detection of hypotension in patients with septic shock.","authors":"Zeyu Jiang, Shixuan Zhang, Yana Yuan, Jiucun Wang, Zixin Hu","doi":"10.21037/cdt-2025-265","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In intensive care units (ICUs), managing septic shock requires maintaining adequate tissue perfusion with vasopressors, most commonly norepinephrine, while avoiding under or over-dosing that can worsen hypotension, organ injury, and adverse effects. Bedside vasopressor titration often depends on clinician judgment and simple rules, with limited tools providing individualized, time-aware guidance or early warning of impending hypotension. ChronoSynthNet aimed to create a data-driven model that learns from routine electronic health record (EHR) time-series data to personalize vasopressor therapy and anticipate deterioration. To develop and validate a dual-task deep learning model that predicts real-time norepinephrine requirements and detects hypotension early in adults with septic shock.</p><p><strong>Methods: </strong>We performed a retrospective cohort analysis using the Medical Information Mart for Intensive Care [MIMIC-IV (2008-2019)] database. Eligible adult ICU stays met Sepsis-3 criteria, received norepinephrine, and had adequate time-series data. ChronoSynthNet integrates a shared Transformer encoder, long short-term memory (LSTM) layers, and a dynamic feature-weighting network to learn cross-variable and temporal relationships. The dataset was split 80/20 into training and internal test sets, with five-fold cross-validation on training data. Classification performance for early hypotension detection was assessed using area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), precision, recall, and specificity; norepinephrine rate prediction performance was assessed using mean squared error (MSE). Ninety-five percent confidence intervals (95% CIs) were calculated for AUROC, recall, and specificity on the internal test set using bootstrap and Wilson methods.</p><p><strong>Results: </strong>ChronoSynthNet achieved AUROC of 0.89 (95% CI: 0.836-0.938) for hypotension classification and MSE of 0.0213 (95% CI: 0.0192-0.0234) for predicting the norepinephrine infusion rate. The model demonstrated high specificity (97%, 95% CI: 96.3-98.3%) and precision (92%, 95% CI: 90.3-93.7%), with a recall of 74% (95% CI: 71.3-76.7%). Hypotension events were predicted a median of 3.5 hours in advance.</p><p><strong>Conclusions: </strong>ChronoSynthNet demonstrated strong performance in early hypotension detection and norepinephrine dose forecasting in ICU patients with septic shock. These findings support its potential role in aiding real-time vasopressor titration and early recognition of hemodynamic instability; prospective multicenter validation is needed before clinical deployment.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"15 4","pages":"833-846"},"PeriodicalIF":2.1000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432635/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular diagnosis and therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/cdt-2025-265","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In intensive care units (ICUs), managing septic shock requires maintaining adequate tissue perfusion with vasopressors, most commonly norepinephrine, while avoiding under or over-dosing that can worsen hypotension, organ injury, and adverse effects. Bedside vasopressor titration often depends on clinician judgment and simple rules, with limited tools providing individualized, time-aware guidance or early warning of impending hypotension. ChronoSynthNet aimed to create a data-driven model that learns from routine electronic health record (EHR) time-series data to personalize vasopressor therapy and anticipate deterioration. To develop and validate a dual-task deep learning model that predicts real-time norepinephrine requirements and detects hypotension early in adults with septic shock.

Methods: We performed a retrospective cohort analysis using the Medical Information Mart for Intensive Care [MIMIC-IV (2008-2019)] database. Eligible adult ICU stays met Sepsis-3 criteria, received norepinephrine, and had adequate time-series data. ChronoSynthNet integrates a shared Transformer encoder, long short-term memory (LSTM) layers, and a dynamic feature-weighting network to learn cross-variable and temporal relationships. The dataset was split 80/20 into training and internal test sets, with five-fold cross-validation on training data. Classification performance for early hypotension detection was assessed using area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), precision, recall, and specificity; norepinephrine rate prediction performance was assessed using mean squared error (MSE). Ninety-five percent confidence intervals (95% CIs) were calculated for AUROC, recall, and specificity on the internal test set using bootstrap and Wilson methods.

Results: ChronoSynthNet achieved AUROC of 0.89 (95% CI: 0.836-0.938) for hypotension classification and MSE of 0.0213 (95% CI: 0.0192-0.0234) for predicting the norepinephrine infusion rate. The model demonstrated high specificity (97%, 95% CI: 96.3-98.3%) and precision (92%, 95% CI: 90.3-93.7%), with a recall of 74% (95% CI: 71.3-76.7%). Hypotension events were predicted a median of 3.5 hours in advance.

Conclusions: ChronoSynthNet demonstrated strong performance in early hypotension detection and norepinephrine dose forecasting in ICU patients with septic shock. These findings support its potential role in aiding real-time vasopressor titration and early recognition of hemodynamic instability; prospective multicenter validation is needed before clinical deployment.

Abstract Image

Abstract Image

Abstract Image

ChronoSynthNet:一项双任务深度学习模型开发和验证研究,用于预测脓毒性休克患者实时去甲肾上腺素剂量和早期发现低血压。
背景:在重症监护病房(icu),处理感染性休克需要血管加压剂(最常见的是去甲肾上腺素)维持足够的组织灌注,同时避免剂量不足或过量,否则会加重低血压、器官损伤和不良反应。床边加压滴定通常取决于临床医生的判断和简单的规则,有限的工具提供个体化、时效性的指导或即将发生的低血压的早期预警。ChronoSynthNet旨在创建一个数据驱动的模型,该模型可以从常规电子健康记录(EHR)时间序列数据中学习,从而个性化血管加压治疗并预测病情恶化。开发并验证一种双任务深度学习模型,该模型可预测成人感染性休克患者的实时去甲肾上腺素需求,并在早期发现低血压。方法:采用重症监护医疗信息市场[MIMIC-IV(2008-2019)]数据库进行回顾性队列分析。符合脓毒症-3标准的成人ICU住院,接受去甲肾上腺素治疗,并有足够的时间序列数据。ChronoSynthNet集成了一个共享的Transformer编码器、长短期记忆(LSTM)层和一个动态特征加权网络,以学习跨变量和时间关系。数据集按80/20分成训练集和内部测试集,对训练数据进行5次交叉验证。采用受试者工作特征曲线下面积(AUROC)、精密度-召回曲线下面积(AUPRC)、精密度、召回率和特异性评估早期低血压检测的分类性能;用均方误差(MSE)评价去甲肾上腺素率预测效果。使用bootstrap和Wilson方法计算内部测试集的AUROC、召回率和特异性的95%置信区间(95% ci)。结果:ChronoSynthNet对低血压分类的AUROC为0.89 (95% CI: 0.836-0.938),预测去甲肾上腺素输注率的MSE为0.0213 (95% CI: 0.0192-0.0234)。该模型具有较高的特异性(97%,95% CI: 96.3-98.3%)和精确度(92%,95% CI: 90.3-93.7%),召回率为74% (95% CI: 71.3-76.7%)。低血压事件平均提前3.5小时预测。结论:ChronoSynthNet在脓毒性休克ICU患者的早期低血压检测和去甲肾上腺素剂量预测方面表现出色。这些发现支持其在帮助实时血管加压滴定和早期识别血流动力学不稳定方面的潜在作用;在临床应用前需要进行前瞻性多中心验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiovascular diagnosis and therapy
Cardiovascular diagnosis and therapy Medicine-Cardiology and Cardiovascular Medicine
CiteScore
4.90
自引率
4.20%
发文量
45
期刊介绍: The journal ''Cardiovascular Diagnosis and Therapy'' (Print ISSN: 2223-3652; Online ISSN: 2223-3660) accepts basic and clinical science submissions related to Cardiovascular Medicine and Surgery. The mission of the journal is the rapid exchange of scientific information between clinicians and scientists worldwide. To reach this goal, the journal will focus on novel media, using a web-based, digital format in addition to traditional print-version. This includes on-line submission, review, publication, and distribution. The digital format will also allow submission of extensive supporting visual material, both images and video. The website www.thecdt.org will serve as the central hub and also allow posting of comments and on-line discussion. The web-site of the journal will be linked to a number of international web-sites (e.g. www.dxy.cn), which will significantly expand the distribution of its contents.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信